Stealth BioTherapeutics (Stealth BioTherapeutics) Scaled Net Operating Assets : -1.44 (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Stealth BioTherapeutics's operating assets for the quarter that ended in Mar. 2022 was $3.08 Mil. Stealth BioTherapeutics's operating liabilities for the quarter that ended in Mar. 2022 was $75.45 Mil. Stealth BioTherapeutics's Total Assets for the quarter that ended in Dec. 2021 was $50.23 Mil. Therefore, Stealth BioTherapeutics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2022 was -1.44.

Stealth BioTherapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Stealth BioTherapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Scaled Net Operating Assets Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Scaled Net Operating Assets

Get a 7-Day Free Trial

-17.37

-38.51

-1.11

-0.65

-2.20

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Scaled Net Operating Assets	Get a 7-Day Free Trial															-1.03	-1.48	-1.79	-1.78	-1.44

Competitive Comparison of Stealth BioTherapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Stealth BioTherapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stealth BioTherapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's Scaled Net Operating Assets falls into.

Stealth BioTherapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Stealth BioTherapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2021 )
=	(Operating Assets (A: Dec. 2021 )	-	Operating Liabilities (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2020 )
=	(3.091	-	81.865)	/	35.848
=	-2.20

where

	Operating Assets		(A: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	50.226	-	47.135
=	3.091

	Operating Liabilities		(A: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	95.521	-	13.656	-	0
=	81.865

Stealth BioTherapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2022 )
=	(Operating Assets (Q: Mar. 2022 )	-	Operating Liabilities (Q: Mar. 2022 ))	/	Total Assets (Q: Dec. 2021 )
=	(3.081	-	75.45)	/	50.226
=	-1.44

where

	Operating Assets		(Q: Mar. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	36.915	-	33.834
=	3.081

	Operating Liabilities		(Q: Mar. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	89.232	-	13.782	-	0
=	75.45

Stealth BioTherapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.